Park Ha Biological (PHH) | Stock Overview & Key Data
Park Ha Biological Performance Comparison
Stock Range
Today's Range
Low: $0.43
High: $0.48
on September 4, 2025
52 Week Range
Low: $0.43
High: $41.49
on September 4, 2025
on July 7, 2025
All-Time High: $41.34 on July 8, 2025
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$153.5M
EPS
-0.72
P/E Ratio (TTM)
26.34
Forward P/E
N/A
P/B Ratio
3.48
PEG Ratio
N/A
Div. Yield
N/A
ROE
-729.77%
Beta
N/A
Debt to Equity
2.15
Financial Highlights
Profitability
Gross Margin
N/A
Operating Margin
-1,591.00%
Profit Margin
91.80%
Returns and Earnings
Return on Assets (TTM)
-298.12%
Return on Equity (TTM)
-729.77%
EBITDA
$816.4K
Net Income (TTM)
$-19.4M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$0.11
Quarterly Revenue Growth (YoY)
45.30%
Quarterly Earnings Growth (YoY)
N/A
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Park Ha Biological PHH | 153.50M Micro-cap | -14.29% | -41.46% | -96.50% | -91.75% | -89.57% | -88.21% | -88.21% | -88.21% |
| Procter & Gamble PG | 411.73B Mega-cap | 0.77% | 4.92% | -5.20% | -9.92% | -4.71% | -9.92% | 13.01% | 14.50% |
| Colgate-Palmolive CL | 75.32B Large-cap | -0.76% | 0.54% | -7.51% | -9.70% | -7.44% | -22.30% | 7.41% | 9.20% |
| Acme United ACU | 163.44M Micro-cap | 3.24% | 2.82% | 7.16% | 13.24% | 15.52% | -1.51% | 50.66% | 83.73% |
| Big Tree Cloud DSY | 75.34M Micro-cap | -6.48% | -18.55% | -20.47% | -48.47% | -68.34% | -76.62% | -85.21% | -85.21% |
| Grove Collaborative GROV | 57.41M Micro-cap | 0.00% | 13.14% | 14.81% | -4.32% | 9.93% | 15.67% | -94.71% | -96.90% |
Ownership & Short Interest
Insider Ownership
73.36%
Institutional Ownership
0.39%
Shares Short
1M
Short Ratio
1.01
Short % of Shares Outstanding
13.93%
Average 10-Day Volume
945K
Average 90-Day Volume
830K
Warning: Undefined variable $nickname in /usr/local/lsws/wordpress/wp-content/themes/egnitech-devyara/templates/stock-overview.php on line 329
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is PHH's 52-week high and low?
- In the last 52 weeks, Park Ha Biological reached a high of $41.49 (on July 7, 2025) and a low of $0.43 (on September 4, 2025).
- What is the market cap and P/E ratio for PHH?
- Curious about Park Ha Biological's size and valuation? Its market capitalization stands at 153.50M. When it comes to valuation, the P/E ratio (trailing twelve months) is 26.34, and the forward P/E (looking ahead) is N/A.
- Does PHH pay dividends? If so, what's the yield?
- As for dividends, Park Ha Biological isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Park Ha Biological's main competitors or similar companies to consider before investing?
When looking at Park Ha Biological, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Procter & Gamble
PG411.73B Consumer Defensive Household & Personal Products -9.92% 13.01% Colgate-Palmolive
CL75.32B Consumer Defensive Household & Personal Products -22.30% 7.41% Acme United
ACU163.44M Consumer Defensive Household & Personal Products -1.51% 50.66% Big Tree Cloud
DSY75.34M Consumer Defensive Household & Personal Products -76.62% -85.21% Grove Collaborative
GROV57.41M Consumer Defensive Household & Personal Products 15.67% -94.71% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Park Ha Biological Technology Co. Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Park Ha Biological's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -729.77%, the Debt to Equity ratio from the most recent quarter is 2.15, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for PHH?
- Looking at Park Ha Biological's growth, its revenue over the trailing twelve months (TTM) was $3M. Compared to the same quarter last year (YoY), quarterly revenue grew by 45.30%, and quarterly earnings saw a YoY growth of N/A.
- How much of PHH stock is held by insiders and institutions?
- Wondering who owns Park Ha Biological stock? Company insiders (like executives and directors) hold about 73.36% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.39%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.